Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®). (Q42206592)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 July 2014
edit
Language Label Description Also known as
English
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).
scientific article published on 10 July 2014

    Statements

    Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®). (English)
    Julien Vergniol
    Juliette Foucher
    Vincent Thibault
    Mona Munteanu
    Wassil Merrouche
    Pascal Lebray
    Marika Rudler
    Olivier Deckmyn
    Hugo Perazzo
    Dominique Thabut
    Vlad Ratziu
    Victor de Ledinghen
    FibroFrance Study Group and the Bordeaux HBV Study Group
    10 July 2014
    994-1003

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit